Here are relevant reports on : clinical-trial-market
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029
The global clinical trial imaging market, valued at US$1.32 billion in 2023, stood at US$1.42 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.07 billion by the end of the period. The increase in R&D spending, growth in the pharmaceutical and biotechnology industry and the increasing number of CROs are driving the clinical trial imaging market.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029
The global biosimulation market, valued at US$3.64 billion in 2023, stood at US$4.24 billion in 2024 and is projected to advance at a resilient CAGR of 16.7% from 2024 to 2029, culminating in a forecasted valuation of US$9.18 billion by the end of the period. The major factors driving the growth of this market include the high rate of clinical trial failures, the increasing necessity to predict drug pharmacokinetics and pharmacodynamics, and the importance of toxicity management.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Electronic Trial Master File (eTMF) Systems Market by Offering (Integrated, Standalone), Function (Analytic, Compliance, Workflow, Audit), Therapeutic (Onco, Cardio, Neuro), End User (Pharma, Biotech, MedDevice), Phase, Region - Global Forecast to 2030
The global electronic trial master file (eTMF) systems market, valued at US$1.21 billion in 2024, stood at US$1.36 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2024 to 2030, culminating in a forecasted valuation of US$2.49 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Application (Clinical Trial (Onco, Rare, Mental Health), RWE, Registery), End User (Govt, Med Device, Pharma) - Global Forecast to 2030
The global electronic clinical outcome assessment (eCOA) solutions market, valued at US$1.94B in 2024, is forecasted to grow at a 16.1% CAGR, reaching US$2.27B by 2025 and US$4.78B by 2030. This growth is primarily driven by increasing investments in research and development from medical device companies looking for digital endpoints.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016)
Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Information systems (CIS) Market (2011-2016)
Clinical information systems include software solutions that enable efficient clinical workflow. Clinical systems include EMR, computerized physician order entry, laboratory information systems, pharmacy information systems, radiology information systems, and PACS. The clinical information systems market in developed countries is growing with higher CAGR, however emerging markets are currently very nascent. Presently, clinical information systems dominate the HIS market due to their high price and rising adoption. Budgetary constraints due to low awareness levels are however restraining market growth. The global clinical information systems market is expected to grow from $1.2 billion in 2009 to $2.8 billion in 2015, at an estimated CAGR of 14.8% from 2010 to 2015.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
